A separate, simplified model compared the biologic dupilumab to PPI and tCS. The primary outcome was the incremental cost-effectiveness ratio (ICER) at 2- and 5-year time horizons. Treatment ...

Dupilumab (Dupixent): This newer medication ... That’s lucky, since phototherapy regimens can cost several thousand dollars. Don’t let the costs of managing your atopic dermatitis treatment ...

additional costs applied to non-responders to account for the cost of treatment failure (see section 3.12). When taking into account the confidential discount for dupilumab, the company's base-case ...

Dupilumab users had at least 0.5 fewer exacerbations ... Overall increases in asthma-related costs associated with the use of these biologic treatments likely reflect the costs of these drugs ...

Among the dupilumab treatment and placebo groups, 69% and 71% had previously used STCs, respectively. Dupilumab safely and efficaciously improved clinical, histologic, endoscopic, and symptomatic ...